Grow Therapy, a New York-based mental health platform, has raised $150M in Series D funding led by TCV and Goldman Sachs Alternatives. The company matches clients to licensed therapists and prescribers for virtual or in-person therapy and medication management. The capital will expand partnerships with insurers, employers, and health systems.
Mental Health Funding Wave Builds
The round comes amid surging investments in insurance-integrated platforms: Talkiatry raised $210M Series D in February 2026, while Headway secured $325M+ total. Alma followed with $220M+, and Rula Health $263M. Grow Therapy's 125+ insurer plans and AI tools target gaps in provider admin and client retention.
Half of Cases Go Untreated
Nearly half of Americans with mental health conditions receive no treatment, despite 220M covered lives via major insurers. Administrative burdens consume 40% of providers' time, inflating costs beyond $9.68B annual market spend. Current solutions fragment matching, billing, and outcomes tracking, leaving 80% of sessions without measured improvement.
AI Cuts Documentation 70%
Grow Therapy equips 26,000+ providers with EHR, billing, AI notetakers reducing documentation time by 70%, and between-session apps. Clients book via filters for specialty, identity, and insurance, achieving 90% match rate and 80% symptom improvement in 30 days. Unlike Headway's credentialing focus, Grow integrates medication management and hybrid care.
Insurance Breadth Tops Rivals
Alma emphasizes billing tools, but Grow's platform covers Medicare/Medicaid across all states with average $21/session costs. Rula Health and SonderMind offer matching, yet lag in insurer count and AI-driven outcomes. Grow's clinically-guided AI recalibrates care continuously, boosting NPS to 85-90.
As TCV's Jay Hoag noted:
"TCV loves backing great entrepreneurs targeting very large market opportunities."
Tier-1 Growth Capital Validates
TCV, with Netflix IPO exits, led alongside Goldman Sachs Growth Equity, prior investor. New backers Menlo Ventures (Anthropic) and BCI join Sequoia and SignalFire, signaling conviction in Grow's $3B valuation and $1B+ run-rate. This mix blends tech growth expertise with healthcare IT focus.
Online Therapy Doubles to $25B
The online therapy market grows from $9.68B in 2024 to $24.8B by 2031 at 14.3% CAGR. Medicare telehealth extensions through 2027 aid virtual expansion. VC poured $682M into digital mental health in H1 2024 alone, fueling platforms like Grow.
Competitors Scale Networks
Headway ($325M+) prioritizes scheduling speed; Alma ($220M+) provider management. Rula ($263M) and SonderMind ($183M) match regionally, but Grow leads with nationwide hybrid access and 10M lifetime sessions. Employer EAP integrations bridge coverage gaps.
Ex-FAANG Founders Drive Scale
CEO Jake Cooper (ex-Blackstone, Forbes 30 Under 30) pairs with CTO Alan Ni (ex-Stripe/Google) and COO Manoj Kanagaraj, MD (Harvard MD/MBA). Their finance-tech-clinical mix secured $328M total raised. Recent hires include SVP Marketing from scaling firms.
Employer Expansions Accelerate Growth
Grow plans flagship employer partnerships like Guidewell/Lucet and Circle Medical referrals. A $16M NYC hub creates 200+ tech/marketing roles. Provider summits and AI launches position for national dominance amid 2M+ clients served.